Two single-stranded nucleic acid binding proteins mCBP and mCTBP were identified by means of their binding to a potential recombination hotspot in LTRs of mouse retro-transposons. Both are nuclear proteins of 35 and 55 kDa respectively. mCBP binds preferentially to oligo dC, mCTBP to oligo dCdT. mCBP was purified and its cDNA was isolated and sequenced.
INTRODUCTION
A topological alteration of Watson-Crick B-DNA structure is a basic requirement for its replication, recombination and transcription (1) . It has been proposed that paranemic, unwound DNA regions are transiently formed during these processes and several non-B DNA topoisomers in addition to single-stranded DNA (ssDNA) have been described in vitro (for rewiev see 2) . To what extent the chromosomal B-DNA can locally undergo transitions into non-B DNA structures also in vivo has been difficult to gauge.
Prokaryotic ssDNA binding proteins (SSB) are recognized as regulatory factors stabilizing the thermodynamically disfavoured ssDNA during replication and recombination processes (rewieved in 3). However, much less is known about their counterparts in mammalian cells.
We have identified a recombination hotspot within the 500bp long terminal repeats (LTR) of mouse retrotransposons LTR-IS/MuRRS (4, 5) . Our experiments revealed a nuclease SI-sensitive homopurine/homopyrimidine region within the LTR-IS sequence that is essential for the hotspot activity. This sequence can assume a non-B DNA conformation in vitro and interacts with at least one ssDNA-binding protein factor. We have proposed that the hotspot activity is brought about by a specific protein interaction with the homopurine/homopyrimidine sequence generating a ssDNA region, which in turn may promote the recombination by facilitating a strand invasion or annealing. Here we have characterized two ssDNA binding factors which interact with the LTR-IS recombinational hotspot.
MATERIALS AND METHODS

Nuclear extracts
Nuclear extracts were prepared from mouse liver or testes as described by Dignam et al. (6) . The liver was cut in pieces and homogenized in PBS with a Wheaton Douncer (S). This material was filtered through two layers of white gauze. Cells were centrifuged and suspended in buffer A (25 mM MES, pH 6.0, 1.5 mM MgCl ? , 10 mM NaCl, 0.5 mM DTT, 0.5 mM PMSF, 1 /tg/ml pepstatin A, 1 /ig/ml leupeptin and 0.1 TlU/ml aprotinin). The pelleted nuclei were extracted in buffer C (50 mM MES, pH 6.0, 25 % glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA and protease inhibitors) and cleared by centrifugation. The extract was dialyzed against buffer D (50 mM MES, pH 6.0, 20 % glycerol, and protease inhibitors) with 50 mM NaCl and stored at -80°C. Testes cellular extracts were prepared as described above with the following modifications. The buffers contained 10 mM (buffer A) or 20 mM (buffer B and D) HEPES pH 7.9 instead of MES and KC1 instead of NaCl.
Protein purification
Nuclear protein extract from 400 g mouse liver was loaded onto a Fast Flow Q Sepharose (Pharmacia) column. Detection of the protein was made by EMS A. The flowthrough fraction containing mCBP was dialysed against buffer D with 30 mM NaCl and loaded onto a Fast Flow S Sepharose (Pharmacia) column. The column was eluted with a step gradient. The 200 mM fraction was diluted with one volume of the buffer D and applied to a Reactive Red 120 (Type 3000, Sigma) column and mCBP was eluted with a step gradient -0.6 M/1.5 M/2.0 M NaCl. The 2.0 M fraction -containing the protein was dialysed against buffer D with 30 mM NaCl. The protein solution was applied to a SP Sepharose High Performance (Pharmacia) and eluted with 250 mM NaCl to concentrate the sample. After a buffer exchange on a PD 10 column (Pharmacia) in buffer E (20 mM HEPES, pH 7.9, 12.5 mM MgCl 2 , 0.2 mM EDTA, 10 % glycerol, 0.5 mM DTT, lftg/ml leupeptin, 0.5 mM PMSF and 100 mM NaCl the protein solution was loaded onto a specific DNA affinity column. The oligonucleotide AAA(TCCCCTAATCTCCCCC-*To whom correspondence should be addressed TTCTCCTTTCC) 3 AAA was coupled with CNBr activated Sepharose CL-6B (Pharmacia) according to the method described by Kadonaga and Tjian (7) with minor modifications. The protein solution was adjusted to 0.2 % n-otylglucoside (Boehringer) and applied on to the DNA affinity column. The DNA affinity column was run by gravity flow and eluted by a step gradient with buffer E containing 0.2 % n-octylglucosid and 0.75 M/1.0 M/1.5M/2.0 M NaCl/2.0 M MgCl 2 respectively. The fractions were dialysed over night against buffer F (20 mM HEPES, 20 % glycerol, 0.2 raM EDTA, 100 mM NaCl, 0.5 mM DTT and 0.5 mM PMSF). mCBP containing fractions were in the 2.5 M NaCl and 2 M MgCl 2 . These fractions were separated on a 12.5 % SDS-PAGE gel and silver stained.
EMSA
The electrophoretic mobility shift assay (EMSA) were performed essentially as described by Fried and Crothers (8) with modifications described by Edelmann et al. (5) . Nuclear extracts, partially purified or purified mCBP/mCTBP were incubated for 10 min on ice with 1 fig of poly d(IC) and competitor DNAs in 19 ml of 0.1% Triton, 4% glycerol, 1 mM EDTA (pH 8.0), 10 mM 2-mercaptoethanol, 10 mMTris-HCl (pH 8.0) and 8o mM NaCl. After addition of 1 pi end-labeled nucleotides (5 -10 fmol), the incubation was continued for 10 min at room temperature. DNA-protein complexes were separated on 4% polyacrylamide gels (187 mM Tris-glycine pH 8.5) and run in 40 mM Tris-glycine buffer (pH 8.8). No poly d(IC) was added in the incubations with purified mCBP.
For the competition experiments of oligo d(C) and oligo r(C) equal ammounts of both end-labeled oligonucleotides were added to the reaction mixture and the purified mCBP was added at last. Both oligonucleotides were 27nt long.
Amino acid sequencing
Amino acid sequence analyses were performed on 477A Applied Biosystems Pulsed Liquid Sequencer according to manufacturers instructions.
cDNA isolation
First strand cDNA was synthesized from 5 ji% of total RNA (mouse liver, 129/Ola x C57B1/6) with 1 /tg of a dT primer YXT (CGAGGGGGAT GGTCGACGGA AGCGACCTTT TTTTT-TTTTT TTTTT) using Superscript II reverse transcriptase (Gibco, BRL). The cDNA was purified from primers with Geneclean (Bio 101, La Jolla, CA). Two degenerated oligonucleotide primers from the N-terminal peptide sequence were used to amplify part of the desired cDNA in a 'nested' PCR. The first PCR was performed with PCR-guesssmer 1 (ATGCA-YGGNA ARGARGTNGG) and oligo Y (CGAGGGGGAT G-GTCGACGG).The PCR products were separated on a 1 % low melting point agarose gel and the DNA from several slices (10 nl melted gel) was used as a template for the second PCR. The second PCR was performed with PCR-guessmer 2 (ATHATH-GGNA ARAARGGNGA) and oligo X (GATGGTCGAC GG-AAGCGACC). PCR reactions (100^1): 0.5 jtM for each primer, 200 nM dNTP's, 1.5 mM MgCl 2 , 2.5 u Taq polymerase (Promega), 35 cycles. The amplified product was cloned, verified by sequencing and used to screen a cDNA library (mouse liver/ZAP vector, Stratagene).
Database searches were performed in the SWISSPROT (University of Geneva, Switzerland) and in the Protein The binding preferences of mCBP and mCTBP to various templates were determined in a competition EMSA as described in Methods. Either purified mCBP or partially purified mCTBP were used. Proteins and competitor DNA or RNA at 50-, 500-, and 1250-fold access were preincubated on ice for 10 min. 
RESULTS
Two protein factors interact with the LTR-IS ssDNA
Single strand oligonucleotides corresponding to the potential non-B DNA sequence of LTR-IS elements (5) were tested for protein binding in a gel retardation assay. After an incubation of the labelled 27nt pyrimidine rich oligonucleotide corresponding to the coding strand of the LTR-IS sequence (Nr. 1 in Table 1 ) in mouse nuclear extracts a single major DNA-protein complex was observed. An additional, larger protein-DNA complex appears first at a higher DNA concentrations (Fig. la) . Denaturing SDS-containing gels of protein bound oligonucleotides after UV-crosslinking allowed an approximate estimate of the size of both factors named mCBP and mCTBP. They run as DNA-protein complexes of about 40 kD and 55 kD (Fig. lb) . Also, this experiment shows that the larger complex remains stable under denaturating conditions and thus it is not a dimer of the smaller one.
Binding site requirements
Several mutated oligonucleotides derived from the LTR-IS sequence and synthetic homopolymers were used to assess the binding specificity of the two factors in a direct and indirect (competition) gel retardation assay. The results are summarized in Table 1 . mCBP binds to oligo dC, oligo rC and allows some substitutions with other nucleotides. mCTBP requires both dC and dT, it does not bind oligo dC or oligo dT homopolymers. It binds also oligo rU and oligo rU-rC, but with a lower affinity (data not shown).
In a direct competition assay between oligo dC and oligo rC mCBP binds preferentially to oligo dC (Fig. 2) .
Since no protein-DNA complexes were seen in EMSA using purified mCBP with dsLTR-IS oligonucleotide we conclude that mCBP does not bind to dsDNA (Table 1) .
Mutations at the 5' end of the wt oligonucleotide (Table 1 ) abolished the complex formation and thus determined the 5' binding boundary. To map the 3' oligonucleotide binding boundary of mCBP we have used the exonuclease activity of the T4 DNA polymerase. Protein-protected nucleotides were determined from the gel shown in Figure 3 . The DNA sequence required for the binding of mCBP estimated from these two assays consist of about 20-22 nts and encompasses the pyrimidine rich region of LTR-IS elements.
Purification and partial sequence of mCBP Screening with the above described oligonucleotide indicated that ssDNA binding factors of a similar size are present in all mouse tissues tested and also in HeLa cells and bovine testis (data not shown). Mouse livers were used as the source of nuclear extracts and ssDNA binding activity was monitored through the purification by EMSA using radioactively labelled C-rich oligonucleotide (Nr. 1 in Table 1 ) as a probe. The nuclear extract was first passed dirough a Fast Flow Q Sepharose and the flowthrough fraction was further purified by chromatography on SP Sepharose High Performance and Red Agarose. As the last step ssDNA-affinity column wim dC-rich oligonucleotide coupled to Sepharose (see Materials and Methods) was employed.
The mCBP was purified as a doublet of about 35 kDa (Fig.  4) . The sequence of the N-terminal 28 amino acids and additional four internal peptides was determined.
Isolation and sequence of the corresponding cDNA clone Two degenerated oligonucleotide primers from the N-terminal peptide sequence were used to amplify part of the desired cDNA in a 'nested set'-PCR as described in Materials and Methods. The amplified product was cloned, verified by sequencing and used to screen a mouse liver cDNA library. Figure 5 shows the predicted amino acid sequence derived from the full-length cDNA clone and the position of the four peptides determined by protein sequencing. The predicted mCBP consists of 331 amino acids and has an isoelectric point of 7.99. The most abundant amino acids in mCBP are isoleucine, glycine and serine. The native protein starts at the position 12 of the predicted protein sequence with VTLT. Database searches showed that the predicted amino acid sequence does not have any extensive homology to any known protein on file other than to the human hnRNP K (9) . As shown in Figure 5 , the overall amino-acid sequence identity to human hnRNP K is 35.6%. and similarity 58.9%. Interestingly, despite of a low degree of homology to KH repeats described in hnRNP-K (10, 11), the canonical motifs of these repeats are well preserved also in mCBP (Fig. 5b) .
DISCUSSION
The relative sequence-specific interaction of mCBP and mCTBP with ssDNA was determined by means of in vitro binding to synthetic oligonucleotides in EMSA and it does not necessarily reflect the structural requirements for binding in vivo. However, a requirement for a specific ssDNA (or RNA) secondary structure seems to be unlikely because mCBP binds with the highest affinity to dC-homopolymers. The only known secondary structures for dC-homopolymers are the recently described C C + hairpins, which however, are formed only at the pH below 7 (12), while mCBP binds to poly dC widiin a broad range of pH 5.4 to 9.5 (data not shown).
mCBP-ssDNA complexes are seen at low ssDNA concentrations, while mCTBP-ssDNA complexes appear first at higher concentrations of the dC-rich oligonucleotide (Fig. 1) . While the amount of the mCTBP-ssDNA complex increases at higher concentration of ssDNA the amount of mCBP remains constant. This behaviour might reflect a higher template affinity of mCBP but its relative lower concentration in the extract as compared to mCTBP. The high affinity of mCBP to dC-rich sequences is further documented by the high salt requirement (2M Mg ++ ) for eluting this factor from the affinity column during its purification.
Only two proteins, the hnRNP proteins J and K, with specificity for C-rich single-stranded nucleic acids were described (9). As shown in Figure 5 , mCBP has significant similarity to the hnRNP protein K. The hnRNP protein K has been identified as a component of hnRNP complexes that assemble on the hnRNA concurrent with transcription (9, 10). More recently it has been shown that the hnRNP protein K binds to the CT-element upstream of the c-myc promoter and augments the c-myc-gene expression in a cw-element-dependent manner (13) . Since, binding sites for the mCBP are contained within upstream sequences of several genes, including the c-myc CT-element, it would be interesting to study its possible involvement in transcription. In this context, it is interesting to note that an insertion of poly dG/poly dC sequence can alter gene expression as well as recombination (14, 15) . The determination of the primary structure of mCBP provides an opportunity to search for its function either in RNA processing or in cellular processes which depend on topological changes of DNA, like transcription, replication and recombination.
